MBB Public Markets I LLC Buys Shares of 2,400 Cardinal Health, Inc. $CAH

Key Points

• MBB Public Markets I LLC acquired a new stake in Cardinal Health, Inc., purchasing 2,400 shares valued at approximately $331,000.
• The company reported a net margin of 0.70% and a quarterly revenue of $60.16 billion, missing the consensus estimate by $0.75 billion.
• Cardinal Health declared a quarterly dividend of $0.5107 per share with a yield of 1.4%, scheduled for payment on October 15th.

MBB Public Markets I LLC acquired a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,400 shares of the company's stock, valued at approximately $331,000.

Several other institutional investors and hedge funds have also bought and sold shares of the company. United Services Automobile Association purchased a new position in Cardinal Health in the first quarter worth $719,000. Great Lakes Advisors LLC raised its position in shares of Cardinal Health by 3.1% in the first quarter. Great Lakes Advisors LLC now owns 3,538 shares of the company's stock worth $487,000 after acquiring an additional 108 shares during the period. Everstar Asset Management LLC acquired a new position in shares of Cardinal Health during the 1st quarter worth about $514,000. Fred Alger Management LLC raised its holdings in Cardinal Health by 471.7% in the 1st quarter. Fred Alger Management LLC now owns 267,231 shares of the company's stock valued at $36,816,000 after acquiring an additional 220,488 shares during the last quarter. Finally, Kestra Investment Management LLC grew its stake in shares of Cardinal Health by 37.3% in the 1st quarter. Kestra Investment Management LLC now owns 4,482 shares of the company's stock valued at $617,000 after buying an additional 1,218 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of CAH stock traded down $0.14 on Friday, hitting $152.34. The stock had a trading volume of 1,162,565 shares, compared to its average volume of 2,399,047. Cardinal Health, Inc. has a 52-week low of $106.54 and a 52-week high of $168.44. The firm has a market capitalization of $36.38 billion, a price-to-earnings ratio of 23.62, a P/E/G ratio of 1.26 and a beta of 0.73. The stock's 50 day moving average is $154.75 and its 200-day moving average is $147.48.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same period in the prior year, the firm posted $1.84 EPS. The firm's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's dividend payout ratio (DPR) is presently 31.63%.

Insiders Place Their Bets

In related news, CEO Stephen M. Mason sold 41,575 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares of the company's stock, valued at $3,881,969.70. This trade represents a 61.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Ola M. Snow sold 28,151 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider directly owned 15,431 shares in the company, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CAH has been the topic of a number of research reports. Citigroup reiterated a "neutral" rating and set a $170.00 target price (up from $157.00) on shares of Cardinal Health in a report on Friday, June 13th. Wells Fargo & Company reissued an "overweight" rating and set a $185.00 price objective (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Robert W. Baird lifted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a report on Wednesday, August 13th. Bank of America boosted their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a report on Tuesday, June 10th. Finally, Argus set a $189.00 price target on shares of Cardinal Health in a report on Friday, August 22nd. Eleven equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Cardinal Health presently has an average rating of "Moderate Buy" and an average price target of $165.93.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.